Patrick Gunning Email

Founder, acting CEO, CSO . Dunad Therapeutics

Cambridge, Cambridge

Location

LinkedIn

Current Roles

Employees:
43
Revenue:
$3.3M
About
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.
Dunad Therapeutics Address
125 Old Broad Street
Cambridge, Cambridge
Dunad Therapeutics Email